Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen, Mats Holmberg, Morten Sørensen, Michael Kosteljanetz, Helle Broholm, Marie-Thérése Stockhausen, Hans Skovgaard Poulsen

    162 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences